On the eve of President-elect Donald Trump's inauguration, here are four strategies that the pharma industry can pursue in response to Trump's criticism of drug manufacturing and drug pricing.
“Getting away with murder” is a harsh condemnation of an industry dedicated to improving and saving lives, but that is what President-elect Donald Trump said of the pharmaceutical industry at his first post-election news conference earlier this month. He further criticized the industry for not manufacturing in the United States and promised to change the way the U.S. government buys drugs.
